
Organic Process Research and Development p. 336 - 345 (2017)
Update date:2022-07-31
Topics:
Goundry, William R. F.
Boardman, Kay
Cunningham, Oliver
Evans, Matthew
Jones, Martin F.
Millard, Kirsty
Rozada-Sanchez, Raquel
Sawyer, Yvonne
Siedlecki, Paul
Whitlock, Brian
Recently, the aminoquinazoline motif has been highly prevalent in anticancer pharmaceutical compounds. Synthetic methods are required to make this structure on a multikilo scale and in high purity. The initial route to aminoquinazoline AZD8931 suffered from the formation of late-stage impurities. To avoid these impurities, a new high-yielding Dimroth rearrangement approach to the aminoquinazoline core of AZD8931 was developed. Assessment of route options on a gram scale demonstrated that the Dimroth rearrangement is a viable approach. The processes were then evolved for large-scale production with learning from a kilo campaign and two plant-scale manufactures. Identification of key process impurities offers an insight into the mechanisms of the Dimroth rearrangement as well as the hydrogenation of a key intermediate. The final processes were operated on a 30 kg scale delivering the target AZD8931 in 41% overall yield.
Contact:0572-2722882
Address:1201,F3,xinghuibandao,
Contact:+86-574-87065746
Address:10th Floor, No.787 Baizhang East Road,
lianyungang jinkang pharmaceutical technology co., ltd.
Contact:008651885445517
Address:Jinshan industrial park, Ganyu county, Lianyungang, Jiangsu Province, 222115, China
Shandong Yaroma Perfumery Co., Ltd.
Contact:+86- 531- 88024598
Address:7-702 Caizhi Central, 59 Gong Ye South Road, Jinan City,250101, P. R. China
SHANDONG CREDAGRI CHEMICAL CO., LTD.
Contact:+86-531-88872050
Address:ROOM 601A, BUILDING 2, SHUNTAI SQUARE, NO. 2000 SHUNHUA ROAD, HI-TECH DEVELOPMENT ZONE, JINAN, CHINA.
Doi:10.1021/ja00191a036
(1989)Doi:10.1016/j.carres.2009.08.028
(2009)Doi:10.1016/j.jfluchem.2005.02.020
(2005)Doi:10.1002/anie.200903558
(2009)Doi:10.1021/acsmedchemlett.7b00296
(2017)Doi:10.1246/cl.1988.1639
(1988)